| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| QDEL - Quidel Corporation | HOLD | 0 @ USD 21.26 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 21.26. The average price that QDEL shares were previous bought at was USD 34.337. The current market price is -38.1% lower than average price they were purchased at. The value of the holding in QDEL has fallen by USD 59,151 compared to the previous valuation of Quidel Corporation |
| TMCI - Treace Medical Concepts Inc | SELL | -112 @ USD 6.23003 | USD -698 | The ETF sold 112 shares of TMCI on 2025-11-06. The shares were previously bought for an average price of USD 7.60423. The Treace Medical Concepts Inc shares were sold for -18.1% lower than average price of previous purchases. This resulted in an overall loss of USD 154 The average price that the ETF previously sold TMCI share for is USD 7.35255 which is higher than the selling price of USD 6.23003 on 2025-11-06. |
| SRDX - SurModics Inc | SELL | -36 @ USD 26.42 | USD -951 | The ETF sold 36 shares of SRDX on 2025-11-06. The shares were previously bought for an average price of USD 30.6595. The SurModics Inc shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 153 The average price that the ETF previously sold SRDX share for is USD 32.9847 which is higher than the selling price of USD 26.42 on 2025-11-06. |
| VREX - Varex Imaging Corp | SELL | -100 @ USD 11.8899 | USD -1,189 | The ETF sold 100 shares of VREX on 2025-11-06. The shares were previously bought for an average price of USD 11.354. The Varex Imaging Corp shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 54 The average price that the ETF previously sold VREX share for is USD 11.9407 which is higher than the selling price of USD 11.8899 on 2025-11-06. |
| OFIX - Orthofix Medical Inc | SELL | -92 @ USD 14.6801 | USD -1,351 | The ETF sold 92 shares of OFIX on 2025-11-06. The shares were previously bought for an average price of USD 15.4031. The Orthofix Medical Inc shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of USD 67 The average price that the ETF previously sold OFIX share for is USD 15.1117 which is higher than the selling price of USD 14.6801 on 2025-11-06. |
| SIBN - Si-Bone Inc | SELL | -90 @ USD 15.1901 | USD -1,367 | The ETF sold 90 shares of SIBN on 2025-11-06. The shares were previously bought for an average price of USD 15.3583. The Si-Bone Inc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 15 The average price that the ETF previously sold SIBN share for is USD 16.1006 which is higher than the selling price of USD 15.1901 on 2025-11-06. |
| IART - Integra LifeSciences Holdings | SELL | -160 @ USD 11.2201 | USD -1,795 | The ETF sold 160 shares of IART on 2025-11-06. The shares were previously bought for an average price of USD 17.8768. The Integra LifeSciences Holdings shares were sold for -37.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,065 The average price that the ETF previously sold IART share for is USD 18.7804 which is higher than the selling price of USD 11.2201 on 2025-11-06. |
| TNDM - Tandem Diabetes Care Inc | SELL | -162 @ USD 13.33 | USD -2,159 | The ETF sold 162 shares of TNDM on 2025-11-06. The shares were previously bought for an average price of USD 20.954. The Tandem Diabetes Care Inc shares were sold for -36.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,235 The average price that the ETF previously sold TNDM share for is USD 24.8354 which is higher than the selling price of USD 13.33 on 2025-11-06. |
| AXGN - Axogen Inc | SELL | -100 @ USD 23.99 | USD -2,399 | The ETF sold 100 shares of AXGN on 2025-11-06. The shares were previously bought for an average price of USD 16.3377. The Axogen Inc shares were sold for 46.8% higher than average price of previous purchases. This sale made a profit of USD 765 The average price that the ETF previously sold AXGN share for is USD 13.4622 so the ETF has sold 100 shares on 2025-11-06 at a higher price than the previous selling average. |
| NVCR - Novocure Ltd | SELL | -236 @ USD 11.27 | USD -2,660 | The ETF sold 236 shares of NVCR on 2025-11-06. The shares were previously bought for an average price of USD 17.8097. The Novocure Ltd shares were sold for -36.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,543 The average price that the ETF previously sold NVCR share for is USD 20.5766 which is higher than the selling price of USD 11.27 on 2025-11-06. |
| CNMD - CONMED Corporation | SELL | -70 @ USD 44.2101 | USD -3,095 | The ETF sold 70 shares of CNMD on 2025-11-06. The shares were previously bought for an average price of USD 56.641. The CONMED Corporation shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 870 The average price that the ETF previously sold CNMD share for is USD 63.9875 which is higher than the selling price of USD 44.2101 on 2025-11-06. |
| ATRC - AtriCure Inc | SELL | -112 @ USD 31.5001 | USD -3,528 | The ETF sold 112 shares of ATRC on 2025-11-06. The shares were previously bought for an average price of USD 35.4391. The AtriCure Inc shares were sold for -11.1% lower than average price of previous purchases. This resulted in an overall loss of USD 441 The average price that the ETF previously sold ATRC share for is USD 34.7102 which is higher than the selling price of USD 31.5001 on 2025-11-06. |
| ENOV - Enovis Corp | SELL | -130 @ USD 28.42 | USD -3,695 | The ETF sold 130 shares of ENOV on 2025-11-06. The shares were previously bought for an average price of USD 36.4594. The Enovis Corp shares were sold for -22.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,045 The average price that the ETF previously sold ENOV share for is USD 39.3893 which is higher than the selling price of USD 28.42 on 2025-11-06. |
| OMCL - Omnicell Inc | SELL | -104 @ USD 35.7599 | USD -3,719 | The ETF sold 104 shares of OMCL on 2025-11-06. The shares were previously bought for an average price of USD 34.6291. The Omnicell Inc shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 118 The average price that the ETF previously sold OMCL share for is USD 37.6068 which is higher than the selling price of USD 35.7599 on 2025-11-06. |
| PRCT - Procept Biorobotics Corp | SELL | -124 @ USD 31.3 | USD -3,881 | The ETF sold 124 shares of PRCT on 2025-11-06. The shares were previously bought for an average price of USD 59.3385. The Procept Biorobotics Corp shares were sold for -47.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,477 The average price that the ETF previously sold PRCT share for is USD 72.2183 which is higher than the selling price of USD 31.3 on 2025-11-06. |
| LMAT - LeMaitre Vascular Inc | SELL | -46 @ USD 85.6001 | USD -3,938 | The ETF sold 46 shares of LMAT on 2025-11-06. The shares were previously bought for an average price of USD 88.5551. The LeMaitre Vascular Inc shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 136 The average price that the ETF previously sold LMAT share for is USD 92.3896 which is higher than the selling price of USD 85.6001 on 2025-11-06. |
| AORT - Artivion Inc | SELL | -92 @ USD 47.5001 | USD -4,370 | The ETF sold 92 shares of AORT on 2025-11-06. The shares were previously bought for an average price of USD 34.7351. The Artivion Inc shares were sold for 36.7% higher than average price of previous purchases. This sale made a profit of USD 1,174 The average price that the ETF previously sold AORT share for is USD 29.4493 so the ETF has sold 92 shares on 2025-11-06 at a higher price than the previous selling average. |
| ATEC - Alphatec Holdings Inc | SELL | -254 @ USD 19.51 | USD -4,956 | The ETF sold 254 shares of ATEC on 2025-11-06. The shares were previously bought for an average price of USD 13.2192. The Alphatec Holdings Inc shares were sold for 47.6% higher than average price of previous purchases. This sale made a profit of USD 1,598 The average price that the ETF previously sold ATEC share for is USD 11.4275 so the ETF has sold 254 shares on 2025-11-06 at a higher price than the previous selling average. |
| INSP - Inspirit Energy Holdings Plc | SELL | -60 @ USD 83.8099 | USD -5,029 | The ETF sold 60 shares of INSP on 2025-11-06. The shares were previously bought for an average price of USD 135.25. The Inspirit Energy Holdings Plc shares were sold for -38.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,086 The average price that the ETF previously sold INSP share for is USD 151.19 which is higher than the selling price of USD 83.8099 on 2025-11-06. |
| ITGR - Integer Holdings Corp | SELL | -76 @ USD 66.6401 | USD -5,065 | The ETF sold 76 shares of ITGR on 2025-11-06. The shares were previously bought for an average price of USD 117.637. The Integer Holdings Corp shares were sold for -43.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,876 The average price that the ETF previously sold ITGR share for is USD 126.077 which is higher than the selling price of USD 66.6401 on 2025-11-06. |
| LIVN - LivaNova PLC | SELL | -118 @ USD 49.57 | USD -5,849 | The ETF sold 118 shares of LIVN on 2025-11-06. The shares were previously bought for an average price of USD 46.7757. The LivaNova PLC shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 330 The average price that the ETF previously sold LIVN share for is USD 47.9293 so the ETF has sold 118 shares on 2025-11-06 at a higher price than the previous selling average. |
| NVST - Envista Holdings Corp | SELL | -372 @ USD 19.48 | USD -7,247 | The ETF sold 372 shares of NVST on 2025-11-06. The shares were previously bought for an average price of USD 19.1276. The Envista Holdings Corp shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of USD 131 The average price that the ETF previously sold NVST share for is USD 19.9784 which is higher than the selling price of USD 19.48 on 2025-11-06. |
| TMDX - TransMedics Group Inc | SELL | -74 @ USD 124.98 | USD -9,249 | The ETF sold 74 shares of TMDX on 2025-11-06. The shares were previously bought for an average price of USD 93.1357. The TransMedics Group Inc shares were sold for 34.2% higher than average price of previous purchases. This sale made a profit of USD 2,356 The average price that the ETF previously sold TMDX share for is USD 107.966 so the ETF has sold 74 shares on 2025-11-06 at a higher price than the previous selling average. |
| GKOS - Glaukos Corp | SELL | -124 @ USD 81.7901 | USD -10,142 | The ETF sold 124 shares of GKOS on 2025-11-06. The shares were previously bought for an average price of USD 106.937. The Glaukos Corp shares were sold for -23.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,118 The average price that the ETF previously sold GKOS share for is USD 114.033 which is higher than the selling price of USD 81.7901 on 2025-11-06. |
| TFX - Teleflex Incorporated | SELL | -96 @ USD 108.51 | USD -10,417 | The ETF sold 96 shares of TFX on 2025-11-06. The shares were previously bought for an average price of USD 142.319. The Teleflex Incorporated shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,246 The average price that the ETF previously sold TFX share for is USD 153.207 which is higher than the selling price of USD 108.51 on 2025-11-06. |
| IRTC - iRhythm Technologies Inc | SELL | -70 @ USD 177.4 | USD -12,418 | The ETF sold 70 shares of IRTC on 2025-11-06. The shares were previously bought for an average price of USD 129.4. The iRhythm Technologies Inc shares were sold for 37.1% higher than average price of previous purchases. This sale made a profit of USD 3,360 The average price that the ETF previously sold IRTC share for is USD 121.056 so the ETF has sold 70 shares on 2025-11-06 at a higher price than the previous selling average. |
| MASI - Masimo Corporation | SELL | -100 @ USD 143.84 | USD -14,384 | The ETF sold 100 shares of MASI on 2025-11-06. The shares were previously bought for an average price of USD 154.973. The Masimo Corporation shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,113 The average price that the ETF previously sold MASI share for is USD 168.371 which is higher than the selling price of USD 143.84 on 2025-11-06. |
| GMED - Globus Medical | SELL | -246 @ USD 61.71 | USD -15,181 | The ETF sold 246 shares of GMED on 2025-11-06. The shares were previously bought for an average price of USD 70.2905. The Globus Medical shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,111 The average price that the ETF previously sold GMED share for is USD 71.7087 which is higher than the selling price of USD 61.71 on 2025-11-06. |
| BAX - Baxter International Inc | SELL | -1,116 @ USD 17.98 | USD -20,066 | The ETF sold 1116 shares of BAX on 2025-11-06. The shares were previously bought for an average price of USD 27.4613. The Baxter International Inc shares were sold for -34.5% lower than average price of previous purchases. This resulted in an overall loss of USD 10,581 The average price that the ETF previously sold BAX share for is USD 31.4423 which is higher than the selling price of USD 17.98 on 2025-11-06. |
| PEN - Pennant International Group plc | SELL | -84 @ USD 264.61 | USD -22,227 | The ETF sold 84 shares of PEN on 2025-11-06. The shares were previously bought for an average price of USD 259.067. The Pennant International Group plc shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of USD 466 The average price that the ETF previously sold PEN share for is USD 255.279 so the ETF has sold 84 shares on 2025-11-06 at a higher price than the previous selling average. |
| PEN - PBF Energy Inc | SELL | -84 @ USD 264.61 | USD -22,227 | The ETF sold 84 shares of PEN on 2025-11-06. The shares were previously bought for an average price of USD 259.067. The PBF Energy Inc shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of USD 466 The average price that the ETF previously sold PEN share for is USD 255.279 so the ETF has sold 84 shares on 2025-11-06 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -482 @ USD 74.15 | USD -35,740 | The ETF sold 482 shares of HOLX on 2025-11-06. The shares were previously bought for an average price of USD 67.0007. The Hologic Inc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 3,446 The average price that the ETF previously sold HOLX share for is USD 69.3099 so the ETF has sold 482 shares on 2025-11-06 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -428 @ USD 88.51 | USD -37,882 | The ETF sold 428 shares of ZBH on 2025-11-06. The shares were previously bought for an average price of USD 102.421. The Zimmer Biomet Holdings Inc shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,954 The average price that the ETF previously sold ZBH share for is USD 103.009 which is higher than the selling price of USD 88.51 on 2025-11-06. |
| PODD - Insulet Corporation | SELL | -152 @ USD 323.4 | USD -49,157 | The ETF sold 152 shares of PODD on 2025-11-06. The shares were previously bought for an average price of USD 293.253. The Insulet Corporation shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 4,582 The average price that the ETF previously sold PODD share for is USD 287.126 so the ETF has sold 152 shares on 2025-11-06 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -848 @ USD 58.02 | USD -49,201 | The ETF sold 848 shares of DXCM on 2025-11-06. The shares were previously bought for an average price of USD 75.1618. The DexCom Inc shares were sold for -22.8% lower than average price of previous purchases. This resulted in an overall loss of USD 14,536 The average price that the ETF previously sold DXCM share for is USD 80.3058 which is higher than the selling price of USD 58.02 on 2025-11-06. |
| STE - STERIS plc | SELL | -212 @ USD 260.06 | USD -55,133 | The ETF sold 212 shares of STE on 2025-11-06. The shares were previously bought for an average price of USD 229.731. The STERIS plc shares were sold for 13.2% higher than average price of previous purchases. This sale made a profit of USD 6,430 The average price that the ETF previously sold STE share for is USD 230.157 so the ETF has sold 212 shares on 2025-11-06 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -986 @ USD 74.17 | USD -73,132 | The ETF sold 986 shares of GEHC on 2025-11-06. The shares were previously bought for an average price of USD 74.9346. The GE HealthCare Technologies Inc. shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 754 The average price that the ETF previously sold GEHC share for is USD 77.0619 which is higher than the selling price of USD 74.17 on 2025-11-06. |
| RMD - ResMed Inc | SELL | -316 @ USD 249.65 | USD -78,889 | The ETF sold 316 shares of RMD on 2025-11-06. The shares were previously bought for an average price of USD 244.86. The ResMed Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 1,514 The average price that the ETF previously sold RMD share for is USD 247.731 so the ETF has sold 316 shares on 2025-11-06 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,268 @ USD 82.44 | USD -104,534 | The ETF sold 1268 shares of EW on 2025-11-06. The shares were previously bought for an average price of USD 73.2429. The Edwards Lifesciences Corp shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 11,662 The average price that the ETF previously sold EW share for is USD 73.9802 so the ETF has sold 1268 shares on 2025-11-06 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -618 @ USD 177.39 | USD -109,627 | The ETF sold 618 shares of BDX on 2025-11-06. The shares were previously bought for an average price of USD 201.977. The Becton Dickinson and Company shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 15,195 The average price that the ETF previously sold BDX share for is USD 199.196 which is higher than the selling price of USD 177.39 on 2025-11-06. |
| IDXX - IDEXX Laboratories Inc | SELL | -172 @ USD 713.74 | USD -122,763 | The ETF sold 172 shares of IDXX on 2025-11-06. The shares were previously bought for an average price of USD 508.266. The IDEXX Laboratories Inc shares were sold for 40.4% higher than average price of previous purchases. This sale made a profit of USD 35,342 The average price that the ETF previously sold IDXX share for is USD 480.54 so the ETF has sold 172 shares on 2025-11-06 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -2,764 @ USD 90.06 | USD -248,926 | The ETF sold 2764 shares of MDT on 2025-11-06. The shares were previously bought for an average price of USD 89.4219. The Medtronic PLC shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 1,764 The average price that the ETF previously sold MDT share for is USD 87.2743 so the ETF has sold 2764 shares on 2025-11-06 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -742 @ USD 353.81 | USD -262,527 | The ETF sold 742 shares of SYK on 2025-11-06. The shares were previously bought for an average price of USD 374.89. The Stryker Corporation shares were sold for -5.6% lower than average price of previous purchases. This resulted in an overall loss of USD 15,641 The average price that the ETF previously sold SYK share for is USD 384.069 which is higher than the selling price of USD 353.81 on 2025-11-06. |
| BSX - Boston Scientific Corporation | SELL | -3,196 @ USD 99.05 | USD -316,564 | The ETF sold 3196 shares of BSX on 2025-11-06. The shares were previously bought for an average price of USD 98.19. The Boston Scientific Corporation shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 2,749 The average price that the ETF previously sold BSX share for is USD 97.0181 so the ETF has sold 3196 shares on 2025-11-06 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -3,196 @ USD 99.05 | USD -316,564 | The ETF sold 3196 shares of BSX on 2025-11-06. The shares were previously bought for an average price of USD 98.19. The MULSTRXSSXIMETFP shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 2,749 The average price that the ETF previously sold BSX share for is USD 97.0181 so the ETF has sold 3196 shares on 2025-11-06 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -772 @ USD 547.78 | USD -422,886 | The ETF sold 772 shares of ISRG on 2025-11-06. The shares were previously bought for an average price of USD 509.787. The Intuitive Surgical Inc shares were sold for 7.5% higher than average price of previous purchases. This sale made a profit of USD 29,331 The average price that the ETF previously sold ISRG share for is USD 529.878 so the ETF has sold 772 shares on 2025-11-06 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -3,752 @ USD 124.95 | USD -468,812 | The ETF sold 3752 shares of ABT on 2025-11-06. The shares were previously bought for an average price of USD 128.636. The Abbott Laboratories shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 13,830 The average price that the ETF previously sold ABT share for is USD 127.056 which is higher than the selling price of USD 124.95 on 2025-11-06. |